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Cartilage tissue engineering 
a b s t r a c t 
Bioprinting is a promising tool to fabricate well-organized cell-laden constructs for repair and regener- 
ation of articular cartilage. The selection of a suitable bioink, in terms of composition and mechanical 
properties, is crucial for the development of viable cartilage substitutes. In this study, we focused on the 
use of one of the main cartilage components, hyaluronic acid (HA), to design and formulate a new bioink 
for cartilage tissue 3D bioprinting. Major characteristics required for this application such as printabil- 
ity, biocompatibility, and biodegradability were analyzed. To produce cartilage constructs with optimal 
mechanical properties, HA-based bioink was co-printed with polylactic acid (PLA). HA-based bioink was 
found to improve cell functionality by an increase in the expression of chondrogenic gene markers and 
specific matrix deposition and, therefore, tissue formation. These results indicate that it is a promising 
bioink candidate for cartilage tissue engineering based in 3D bioprinting. 
Statement of Significance 
The recent appearance of 3D printing technology has enabled great advances in the treatment of osteo- 
chondral disorders by fabrication of cartilage tissue constructs that restore and/or regenerate damaged 
tissue. In this attempt, the selection of a suitable biomaterial, in terms of composition and mechanical 
properties, is crucial. In this study, we describe for first time the development of a bioink based on the 
main component of cartilage, HA, with suitable biological and mechanical properties, without involving 
toxic procedure, and its application in cartilage tissue bioprinting. Hybrid constructs prepared by co- 
printing this bioink and thermoplastic polymer PLA provided an optimal niche for chondrocyte growth 
and maintenance as well as mechanical properties necessary to support load forces exerted in native 
tissue. We highlight the translation potential of this HA-based bioink in the clinical arena. 
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(  . Introduction 
Articular cartilage (AC) is a highly specialized connective tissue
hat due to its compositional and structural nature has a limited
apacity for self-repairing, a condition that leads to degeneration
pon injury. In this situation, clinical intervention is necessary. Re-
ently, tissue engineering (TE) has emerged as an inter-disciplinary
eld to develop new therapeutic approaches for cartilage regen-
ration based on the generation of biological substitutes that re-
tore, maintain, or improve damaged tissue function [1 , 2] . Gen-
rally, this is performed by culturing the cells in a 3D mesh or
caffold that provides a mechanically supportive microenvironment
3] . 
The introduction of three-dimensional (3D) bioprinting technol-
gy in TE has led a great progress as it allows to attain tissue
nalogue structures by controlled 3D deposition of living cells and
upporting biomaterials in a spatial location [4] . To date, several
ispensing techniques have been developed to mimic the anatomy
f articular cartilage tissue. These include inkjet, laser-induced for-
ard transfer (SLA), stereolithography, and Extrusion-based plot-
ing (EBP), which is the most common and affordable bioprint-
ng method [5] . Using this specific technique, researchers have
eported the creation of cartilage-like constructs solely by the com-
ination of different hydrogels [6–13] , although the most suitable
trategy has involved simultaneous deposition of thermoplastic
olymers (e.g. polylactic acid, PLA), as structural materials capa-
le of resisting mechanical forces, and hydrogels as cell carriers
14–16] . In this case, there are many biomaterial candidates that
rovide a suitable microphysical environment and excellent bio-
ompatibility [10 , 17 , 18] , but not all provide the physiological con-
itions of the living tissue to obtain functional engineered con-
tructs. 
Hyaluronic acid (HA) is a structurally simple, polymeric gly-
osaminoglycan (GAG) composed of repeating units of β−1,4- d -
lucuronic acid- β−1,3-N-acetyl-Dglucosamine residues. It is a main
omponent in the extracellular matrix (ECM) of AC, where it plays
 critical role in maintaining cartilage homeostasis by the regula-
ion of cell functions, including promotion of chondrogenic phe-
otype, and production and retention of matrix components [19] .
espite these bioactive properties and excellent biocompatibility
hat have made HA a fascinating biomaterial for cartilage tissue
ngineering, it lacks the physical properties required for its ap-
lication in 3D extrusion-based bioprinting (EBB). Among these
imitations, solutions of this material do not have enough vis-
osity to ensure stability in the reservoir for the time of the
rinting procedure, and therefore, homogeneous three-dimensional
istribution of the cells. HA also lacks gelation abilities that
re essential to maintain 3D structure after the printing process
20 , 21] . 
Several strategies based on modification of HA have allowed
he development of HA formulations suitable for use as a bioink
22–26] . However, most of them have some issues that can limit
heir practical use. In this context, combination with natural
elling agents has gained considerable attention as they do not
nvolve any toxic or complex process during preparation and gel
ormation [27–29] . In the present study, a new HA-based bioink
as designed by including alginate, a biomaterial outstanding for
ts biocompatibility, mechanical properties and fast gelation kinet-
cs [14 , 30 , 31] to 3D bioprint a hybrid construct for AC regeneration.
echanical properties of the HA-based bioink and 3D hybrid con-
truct were analyzed and the biological feasibility of the bioprint-
ng construct was assessed by using primary human chondrocytes
nd testing cell viability, karyotyping, proliferation, and protein and
ene expression. . Materials and methods 
.1. Isolation and culture of chondrocytes 
Articular cartilage was obtained from the AC of osteoarthritic
atients. Ethical approval for the study was obtained from the
thics Committee of the Clinical University Hospital of Málaga,
pain. Informed patient consent was obtained for all samples used
n this study. None of the patients had a history of inflammatory
rthritis or crystal-induced arthritis. Human articular chondrocytes
ere isolated as previously described [32] . Briefly, cells were ob-
ained from the femoral side by selecting the non-overload com-
artment: lateral condyle in varus knees and medial condyle in
he valgus cases. Only cartilage that macroscopically appeared rela-
ively normal was used for this study. Chondrocytes were grown in
MEM–high glucose (Sigma) supplemented with 10% fetal bovine
erum (Gibco), 50 μg/μL of l -ascorbic acid 2-phosphate (Sigma),
0 μg/μL of l -proline (Sigma), 1% penicillin-streptomycin (Sigma)
nd 1% insulin-transferrin-selenium (Gibco) in a 25-cm 2 cell cul-
ure flask. Cells were incubated at 37 °C humidified atmosphere
ontaining 5% CO 2 and expanded in a monolayer for 7–10 days be-
ore the experiment. 
.2. Quantitative real-time PCR (qPCR) 
Total messenger RNA (mRNA) was isolated using TriReagent
Sigma) and reverse-transcribed into cDNA using the Reverse Tran-
cription System kit (Promega). The quantitative real-time poly-
erase chain reaction (qRT-PCR) was conducted using a SYBR
reen master mix (Promega) according to the manufacturer’s rec-
mmendations. Gene expression levels for aggrecan (ACAN), type
I collagen (COL2A1), Sox-transcription factor 9 (SOX-9), type I
ollagen (COL1A1) and type X collagen (COL10A1) levels were
ormalized to those of the housekeeping gene glyceraldehyde 3-
hosphate dehydrogenase (GADPH) and shown as fold change rel-
tive to the value of the control sample (alginate hybrid scaffold).
he primer sequences are reported in previous work [32] . All the
amples were done in triplicate for each gene. 
.3. Preparation of the HA-based bioinks 
The bioink formulation consisted of an HA-based hydrogel ca-
able of forming physically cross-linked gels in the presence of cal-
ium. It was prepared by dissolving HA and alginate (A) in deion-
zed water at concentrations of 1% (w/v) and 2% (w/v), respectively
 Fig. 1 A). This formulation was identified to have greater effective-
ess in chondrogenesis assays, after testing a wide range of HA
oncentrations by gene expression (Figure S1). Moreover, this par-
icular concentration is the most commonly used for clinical visco-
upplementation. Finally, to obtain the final bioink, chondrocytes
ere suspended at the desired concentration (1 × 1010 6 cells/mL)
n the solutions ( Fig. 1 B). Two other hydrogels consisting of A at
% (w/v) and HA at 1% (w/v) respectively, were also prepared as a
ontrol. 
.4. Rheological tests of bioinks 
All the rheological tests were carried out in a torsional rheome-
er MCR302 (Anton Paar, Austria) at 25 °C. 
.4.1. Steady shear and linear viscoelasticity of the hydrogels 
The hydrogels were measured using cone-plate geometry
50 mm diameter and 1 ° angle). The shear viscosity was obtained
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Fig. 1. (a) Hydrogel formulation. (b) Preparation of HA-based bioink (hydrogel). (c) 


















































































in a three-step protocol. First, the hydrogel was pre-sheared at
10 0 0 s − 1 for 1 min. Then, it was allowed to rest (without a shear
rate applied) for 1 min. Finally, the shear rate was logarithmically
increased from 0.1 to 10 0 0 s −1 (acquisition time of 5 s) for 5 min. 
The viscoelastic properties were also investigated in dynamic
oscillatory shear. We performed strain amplitude and frequency
sweeps, again, in a three-step process. The first and second steps
were similar to the ones for steady shear tests while the third
one consisted of either increasing the strain amplitude from 10%
to 10 0 0% at a constant frequency of 1 Hz, or decreasing the exci-
tation frequency from 100 to 0.1 Hz at a constant strain amplitude
of 10%. 
2.4.2. Dynamic oscillatory shear behavior of the crosslinked hydrogels
HA-based hydrogels were crosslinked using calcium (100 mM
CaCl 2 ) in molds having disk-like shapes and then placed on top of
the rheometer for testing. The mechanical properties were mea-
sured using a plate-plate geometry with 20 mm diameter and
5 mm gap. The viscoelastic properties were determined as follows.
After the specimen was placed on top of the lower base of the
rheometer, the rheometer head was displaced downwards at a con-
stant velocity of 10 μm/s. Once the head registers a normal force
that is larger than 0.5 N, the rheometer head stops and the normal
force is kept constant at 0.5 N for 30 more seconds. Finally, the
sample is subjected to an oscillatory shear of 0.1% strain amplitude
and an excitation frequency of 1 Hz at a constant normal force of
0.5 N to quantify the viscoelastic properties. .4.3. Degradation rate of HA-based bioinks using linear 
iscoelasticity 
HA-based bioinks were prepared, as previously described and
hen crosslinked to form a disk-like shape. The degradation rate of
he bioinks was studied through the evolution of their viscoelastic
oduli as a function of time over a month. We prepared as many
dentical samples as time points, keeping them under the same
ulture conditions up to the measurement time point. For the ex-
eriments, we followed the same rheological protocol as previously
escribed. 
.5. Bioprinting of hybrid 3D scaffolds with HA-based bioinks 
The design of the construct was based on the combination of
he positive attributes of the PLA synthetic polymer that confers
uperior mechanical properties and natural biopolymers (HA and
), which provide a supportive native-like environment for cell en-
apsulation. It was fabricated using the REGEMAT V1 bioprinter as
reviously described [16] . Briefly, the bioprinting process involves a
ual-step procedure: deposition of a thermoplastic polymer frame-
ork and injection of the bioink and CaCl 2 solution into that struc-
ure. First, PLA was deposited by head (at 200 °C) in a layer-by-
ayer manner to generate the framework that was previously de-
igned using software REGEMAT 3D designer (porous cylinder-type
tructure, 10 × 10 mm; 600 μm pore size). After printing 4 lay-
rs, the HA-based bioink with chondrocytes loaded in a syringe
3 cc) was injected into the pores of PLA structure. Then, it was
hysically cross-linked by following with an injection of 100 mM
aCl 2 , loaded into another syringe ( Fig. 1 C). This procedure was
epeated until the scaffold was completely built. We bioprinted as
any cell-laden scaffolds as were needed for following analytical
tudies. Finally, hybrid constructs were cultured in growth medium
t 37 °C in 5% CO 2 atmosphere. 
.6. Mechanical testing of the scaffolds 
The mechanical properties of the hybrid constructs were inves-
igated using compression and shear tests. The test consisted of the
ollowing stages. First, a scaffold with cylindrical shape (20 mm di-
meter and 5 mm height) was placed onto the base of the rheome-
er. Then, the rheometer head was approached at a constant speed
10 μm/s) up to a normal force reading of 40 N. At that stage, the
pecimen was oscillatory sheared according to a strain amplitude
f 0.0 0 0 01% at a frequency of 1 Hz and a normal force of 40 N
o determine the shear viscoelastic moduli and finally the upper
late was separated at a constant speed (10 μm/s). The compres-
ion and tension steps allowed to determine the compression mod-
lus, while the shearing step allows us to determine the shearing
odulus. 
.7. Cell viability 
The Live/Dead assay (Thermo Fisher Scientific) was used to
valuate the viability of chondrocytes previous to and after the bio-
rinting process at 24 h, 1, 2, 3, and 4 weeks in culture. Briefly,
ell-laden scaffolds were washed and stained with 4 μL of 2 μM
alcine AM and 8 μL of 4 μM EthD-I in 4 mL of sterile phosphate-
uffered saline (PBS), incubated in the dark for 30 min. After wash-
ng with PBS, the scaffolds were observed using a confocal micro-
cope and imaged. Green fluorescence was visualized in live cells
nd red fluorescence in dead cells using two different filters. Im-
ges were analyzed with Image J software (v. 1.52i, USA). For each
ell type, six regions were counted to obtain an average value of
he percent of viable cells ( n = 3). 






















































































































w  .8. Cell proliferation 
The proliferation rate of chondrocytes encapsulated in 3D hy-
rid constructs were assessed by colorimetric alamar Blue (aB) as-
ay (Thermo Fisher Scientific) at day 0 and 1, 2, 3 and 4 weeks
fter bioprinting. Cell-free 3D scaffolds were used as controls, and
ata was normalized to the appropriate control. Briefly, at each
ime point, scaffolds were incubated with 10 μL of aB solution per
00 μL of medium and incubated for 3 h. The fluorescence inten-
ity was measured using a plate reader (Synergy HT, BIO-TEK) with
xcitation and emission wavelengths of 570 and 600 nm, respec-
ively. The absorbance data was represented as fold increase to day
. Experiments were performed in triplicate ( n = 3). 
.9. Karyotype analysis 
Karyotype analysis was performed before and after bioprinting
rocess by G band techniques. To obtain chromosomal prepara-
ions, chondrocytes were treated with 0.8 mg/mL colchicine and
ncubated at 37 °C for 1.15 h. Then, cells were collected and di-
ested into 0.05% trypsin, continued with a hypotonic treatment
sing 0.075 mol/L KCl and fixation in the mixture of methanol
nd glacial acetic acid. Mitosis metaphase spreads were stained
ith Giemsa dye and imaged under the optical microscope. Ap-
roximately 20 metaphases were analyzed under the microscope.
he final result was described to account for the recommendations
rom the International System for Human Cytogenetic Nomencla-
ure. 
.10. Biochemical assays 
For GAG quantification, 3D hybrid constructs were digested in
 mL of papain solution (125 mg/mL papain in 0.1 M sodium phos-
hate with 5 mM EDTA and 5 mM cysteine-HCl at pH 6.5) for 16 h
t 60 °C. Then, they were centrifuged at 10,0 0 0 × g for 5 min.
he supernatant was used for chemical assay, and the quantity of
AGs was measured by the dimethylmethyleneblue (DMB) colori-
etric assay. The supernatant was mixed with DMB solution to
ind GAGs. The content was calculated based on a standard curve
f sulfate chondroitin from shark cartilage (Sigma) at 530 nm on a
icroplate spectrophotometer and normalized with cell-free laden
caffolds. The DNA content was determined by a Hoechst assay.
he supernatant was reacted with the Hoechst dye for 30 min in
he dark. The intensity of fluorescence was screened with a 96-
ell plate reader (excitation at 360 nm and emission at 460 nm).
he content was calculated using thymus DNA for a standard curve
Sigma). 
For type II collagen quantification, 3D hybrid constructs were
igested by pepsin (1 mg/mL) in 0.5 N acetic acid for 48 h at
 °C followed by adding 1 mg/mL pancreatic elastase solution at
 °C for 24 h. Finally, the samples were neutralized with 1 M
ris base. The insoluble material was removed by centrifugation at
0,0 0 0 rpm at room temperature for 5 min, and the supernatant
as collected for assay. The quantitative analysis was performed
sing a commercially available Type II collagen ELISA kit (Chon-
rex), according to manufacturer’s instructions and measured on
icroplate Spectrophotometer at 490 nm. 
.11. Statistical analysis 
Statistical analysis was performed using SPSS software (ver-
ion 17.0). Unpaired t -test was used for single comparison between
roups. All results are shown as mean and standard deviations. A
ifference between the mean values for each group was considered
tatistically significant when the p value was less than 0.05. . Results and discussion 
.1. Effect of HA concentration 
Previous to bioink formulation, we determined the optimal HA
oncentration for preservation and improvement of chondrogenic
henotype. It was analyzed by gene expression of chondrocytes
mbedded in hydrogels at different concentrations of HA after 14
ays in culture. These concentrations were selected based on those
eported in the literature [33–35] . As shown in Figure S1, the addi-
ion of HA to alginate hydrogel caused an overall increased expres-
ion of chondrogenic markers such as Collagen type II (COL2A1),
ggrecan (ACAN), and SOX9, especially in 1% HA. Significantly
igher levels for all these genes were observed than those for the
emaining conditions, although the levels were similar to 0.5% and
% in the case of ACAN and SOX9, respectively. Moreover, there
as a trend toward a reduction of dedifferentiation markers, such
s fibrotic marker collagen type I (COL1A1) [36] and hypertrophic
arker COL10A1 [37] , in presence of HA. However, it was not sta-
istically significant in comparison to alginate, whose expression
as not detectable or very low for all conditions studied. . Alto-
ether, these results indicated that 1% HA provided the most favor-
ble environment to preserve and enhance the phenotype of chon-
rocytes. 
.2. Characterization of the bioink 
The rheological properties of the bioink are crucial for an opti-
al performance in the extrusion process through the syringe. For
his reason, both steady shear and dynamic oscillatory properties
ere investigated. 
.1.1. HA-based hydrogels 
The viscosity versus shear rate curves for the three hydrogels
ased on A, HA and A + HA, are shown in Fig. 2 A. As observed,
 exhibits a constant shear viscosity as expected from a Newto-
ian material. However, HA alone or combined with A exhibits a
hear thinning behavior (i.e. decrease of viscosity with shear rate)
hat is expected in view of the large molecular weight of the HA
olecule. This result is in accordance with the literature where it
as previously reported that HA was widely explored as a “build-
ng block” in various bioink formulations for cartilage bioprinting
n CTE because of its viscoelastic and bioactive properties [38] .
ven though the shear rates achieved in the extrusion process are
xpected to be larger than the maximum shear rates achieved in
he rheometer (a rough estimation can be obtained from the flow
ate and the diameter of the nozzle 250 μm), the viscosity level
s expected to remain below 100 mPa. Therefore, the bioinks are
xpected to be easily extruded without significant effort [17 , 39] . 
The strain amplitude sweep tests for the three hydrogels inves-
igated exhibit a linear viscous behavior (G ′′ ’ > G ′ ) in a wide range
f strains for all hydrogels ( Fig. 2 B). These results are in agreement
ith viscosity data in Fig. 2 A. The samples show purely dissipative
olutions. 
In Fig. 2 C, we show frequency sweep results in the linear vis-
oelastic regime (i.e. low strain region in Fig. 2 B) for the three hy-
rogels investigated. As expected, the data demonstrates that the
ydrogels behave as viscous materials in a wide range of frequen-
ies (G ′′ > G ′ ). The slope of the G’’ curve agrees well with the shear
iscosity shown in Fig. 2 A. 
.1.2. Crosslinked HA-based hydrogel 
As stated in the Materials and Methods section, calcium so-
utions were used to crosslink the hydrogel. This particular gela-
ion process is extraordinarily rapid and cannot be followed in situ
ithin the rheometer. Once the cylinders were completely gelled
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Fig. 2. Rheological characterization. (a) Viscosity curves of alginate, hyaluronic acid (HA) and A + HA hydrogels. (b) Strain amplitude sweeps in dynamic oscillatory shear 
of the three hydrogels. Frequency = 1 Hz. (c) Frequency sweep in dynamic oscillatory shear of the three hydrogels. Strain amplitude = 0.1%. (d) Viscoelastic moduli of 
HA-based hydrogels and crosslinked HA-based hydrogel ( A + HA). Compression (e) and viscoelastic moduli (f) of the crosslinked HA-based hydrogel over 1 month in culture. 




























































c  (after 1 h in the presence of CaCl 2 ), the specimens were loaded
onto the rheometer and the tests initiated. 
The viscoelastic moduli of the crosslinked HA-based hydrogel
are shown in Fig. 2 D together with those obtained from the so-
lutions in the low strain amplitude region in strain amplitude
sweeps (see Fig. 2 B). As expected, the storage modulus G ′ of the
crosslinked HA-based hydrogel becomes larger than the loss mod-
ulus G ′′ and clearly above those measured in hydrogels. The stor-
age modulus reaches a value of approximately 3 kPa. In accordance
with Honghyun Park et al. [40] , this value is sufficient for the gel
to hold the cells in place, while still allowing them to proliferate
and grow. 
3.1.3. Crosslinked HA-based bioink degradation 
The long-term stability of the crosslinked HA-based bioink was
investigated through changes in material rheological behavior with
time. Compression and viscoelastic moduli were recorded over a
culture period of 4 weeks. Both moduli exhibited similar trends.
As shown in Fig. 2 E and F, there was a significant decrease in both
moduli after 1 week, probably due to the gel dissociation by ionic
exchange of the Ca + 2 with Na + in the culture medium and the
degradation of HA by hyaluronidases secreted from cells [41–43] ,
but then they were kept unchanged until the end of the test. A
very slight increase with time was observed that could be corre-
lated to new tissue synthesis. 
3.2. Mechanical properties of the bioprinted scaffolds 
The mechanical properties of the bioprinted scaffolds are cru-
cial for clinical applications. Hence, we analyzed the compression
moduli for the three scaffolds investigated ( Fig. 3 A). The range be-
tween 1.5 and 3 MPa and HA incorporation increased the modulus
as compared to A alone-PLA scaffolds and even more than PLA-
alone construct. This enhancement in mechanical properties could
be related to the large colloid osmotic pressure and viscoelastic-ty properties of HA that provides load bearing capability. After 4
eeks in culture, their modulus increased, but there was no sig-
ificant difference between them. In Fig. 3 B, we show the shear
viscoelastic) moduli of the construct. The loss moduli are negli-
ible while the storage moduli are in the range of MPa. Similar
o compression moduli, their values increased after culture period,
aintaining the difference between them. These values, for com-
ression and shear moduli, are comparable to those of healthy hu-
an articular cartilage [44 , 45] . Moreover, they are in agreement
ith results from other 3D constructs that have been used for CTE
26 , 46–49] . 
.3. Cell viability of the bioprinted scaffolds 
The main goal of fabrication using 3D bioprinting technology
s to achieve high cell viability in constructs. During this process,
hondrocytes are exposed to shear stress induced by nozzle and
igh melting temperatures of PLA thermoplastic that induce dam-
ge. Thus, an essential requisite when designing a bioink would be
ell support and protection during and after this procedure. When
ell viability was examined by live/dead staining, it was found to
etain greater than 85% of cell viability with no significant changes
rior to and after printing ( Fig. 4 A and B). This suggested that such
ell protection was partly associated with shear thinning behavior
f bioink and the bioprinting system used, as previously reported
16] . 
This high cell viability was maintained in the cell-laden con-
tructs and increased for long-term culture ( Fig. 5 A–F). Remark-
bly, predominant green fluorescence evidenced that chondrocytes
ere viable and well distributed into constructs over 1 month in
itro. These results also show morphology retention during their
esidence in it, which is very important for their functions. In ad-
ition, high cell viability was confirmed by proliferation assay data,
hich indicated cell growth over this period with a significant in-
rease in PLA-HA-based bioink in comparison to control constructs
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Fig. 3. Mechanical properties of bioprinted constructs. Compressive (a) and viscoelastic (b) modulus of PLA scaffold, hybrid scaffold of PLA-A bioink and PLA-HA-based bioink 
at day 0 and 28 days in culture. (mean ± SD, n = 3, Student’s t -test, ∗p < 0.05). 
Fig. 4. Cell viability during bioprinting process. Live/Dead cell imaging analysis. (a) Representative image of bioprinted human chondrocytes in HA-based bioink, showing 
live (green) and dead (red) cells. (b) Percentage of chondrocyte viability in HA-based bioinks before and after the bioprinting process. (c) Karyotype of chondrocytes before 
















t  ith A ( p < 0.05) ( Fig. 5 G). This evidenced the positive effect of
A on cell proliferation that has been reported in several studies
50–52] . 
.4. Karyotype analysis 
Cells were tested for genomic stability using a conventional
nalysis by G band techniques to assess whether the chondro-
ytes maintained their normal karyotype pre- and post-bioprinting.
he karyotyping analysis of chondrocytes showed no karyotypehanges before and after the bioprinting process obtaining a typ-
cal diploid karyotype (46, XX) ( Fig. 4 C). Cytogenetic karyotype
nalysis also revealed chromosomal stability, without any aberra-
ion related to the procedure. 
.5. Evaluation of neocartilage formation in hybrid bioprinted 
onstructs 
The ability to secrete a native ECM is another important issue
o consider in this bioprinted construct as a substitute for cartilage
120 C. Antich, J. de Vicente and G. Jiménez et al. / Acta Biomaterialia 106 (2020) 114–123 
Fig. 5. Cell viability of chondrocytes in bioprinted construct with respect to time in culture. Representative image of bioprinted human chondrocytes in HA-based bioink 
after 24 h (a), 1 (b), 2 (c), 3 (d) and 4 weeks (e) in culture, showing live (green) and dead (red) cells. (f) Percentage of chondrocyte viability in HA-based bioinks with respect 
to time in culture. (g) Cell proliferation inside the HA-based (white) and alginate bioink (black). Error bars represent standard deviations ( n = 3). Scale bar: 100 μm. (For 
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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Fig. 6. Cartilage formation in hybrid 3D bioprinted constructs after 1 month in culture. Quantitative analysis of type II collagen (a) and GAG (b) in the total extract per 
scaffold (in 1 mL). (c) Gene expression levels of hyaline-specific chondrogenic marker genes (COL2A1, ACAN and SOX9), fibrotic maker (COL1A1) and hypertrophic marker 






























































egeneration. The beneficial effect of HA on chondrogenic matrix
roduction has been extensively reported in several studies [26 , 52–
4] , evidencing a stimulatory effect on synthesis of such matrix
omponents, according to various mechanisms [3] . Fig. 6 shows
he capacity of 3D bioprinted hybrid constructs to generate hyaline
artilage-specific ECM. The number of main components of this
atrix such as type II collagen and GAG in hybrid PLA/HA-based
ioink scaffolds after 4 weeks in culture was 18.32 ng and 41.37 μg,
espectively. In both cases, values were significantly higher than
ontrols with A ( Fig. 6 A and B). 
HA regulation of chondrogenic phenotype was also analyzed by
ene expression. In accordance with previous results, we observed
n increased expression of hyaline cartilage-specific gene such as
OX9 in addition to COL2A1 and ACAN, while the expression of
he fibrotic marker gene COL1A1 and the hypertrophic marker gene
OL10A1 were low or undetectable when compared to control with
 ( Fig. 6 C). 
Taken together, these results suggest that bioprinted hybrid
caffold composed by PLA and HA-based bioink potentially sup-
orted AC formation in vitro as demonstrated by cartilage ECM de-
osition and chondrogenic gene expression. 
. Conclusions 
In conclusion, we developed an HA-based bioink to produce
ighly viable and functional bioprinted 3D hybrid structures for
C regeneration. The mixture of HA with A provides the suitable
echanical properties to be used as cell-carrier biomaterial for
onstruct fabrication by 3D bioprinting, that includes printability,
elling abilities, stiffness and good degradability. The application
f this HA-based bioink to 3D bioprinting contributes to the cre-
tion of a proper biomimetic hybrid scaffold for AC regeneration,
ince it promotes chondrogenesis. In the future, we expect to in-
estigate the cartilage regeneration in vivo, using such hybrid con-
tructs in animal models, to achieve a possible clinical applica-
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